PFWA
VRTX icon

Paces Ferry Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$621K Sell
1,250
-36
-3% -$16K 0.23% 59
2026
Q1 		$574K Hold
1,286
– – 0.24% 56
2025
Q4 		$583K Sell
1,286
-21
-2% -$9.05K 0.24% 57
2025
Q3 		$512K Buy
1,307
+16
+1% +$6.69K 0.21% 63
2025
Q2 		$575K Sell
1,291
-61
-5% -$28.1K 0.26% 56
2025
Q1 		$655K Buy
1,352
+116
+9% +$54.1K 0.33% 51
2024
Q4 		$498K Sell
1,236
-58
-4% -$26.9K 0.24% 57
2024
Q3 		$602K Sell
1,294
-7
-0.5% -$3.36K 0.35% 49
2024
Q2 		$610K Sell
1,301
-25
-2% -$10.9K 0.37% 49
2024
Q1 		$554K Sell
1,326
-66
-5% -$27.9K 0.36% 54
2023
Q4 		$566K Sell
1,392
-4
-0.3% -$1.48K 0.39% 54
2023
Q3 		$485K Sell
1,396
-30
-2% -$10.5K 0.38% 55
2023
Q2 		$502K Buy
1,426
+9
+0.6% +$3.03K 0.38% 53
2023
Q1 		$446K Sell
1,417
-116
-8% -$34.8K 0.36% 57
2022
Q4 		$443K Sell
1,533
-51
-3% -$15.5K 0.43% 54
2022
Q3 		$459K Sell
1,584
-44
-3% -$12.7K 0.5% 46
2022
Q2 		$459K Sell
1,628
-439
-21% -$118K 0.45% 50
2022
Q1 		$539K Buy
2,067
+3
+0.1% +$712 0.43% 51
2021
Q4 		$453K Sell
2,064
-96
-4% -$18.7K 0.32% 67
2021
Q3 		$392K Buy
+2,160
New +$422K 0.31% 73
2020
Q4 		– Sell
-27
Closed -$7K – 1077
2020
Q3 		$7K Buy
+27
New +$7.45K 0.01% 499

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Paces Ferry Wealth Advisors's VRTX Position: Q2 2026 in Review

Paces Ferry Wealth Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $16K and leaving 1,250 shares worth $621K. The position accounts for 0.23% of the portfolio, ranked #59.

Paces Ferry Wealth Advisors first reported a position in VRTX in Q3 2020 and has held it in 21 quarters since. The position peaked at $655K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Paces Ferry Wealth Advisors held 1,250 shares of Vertex Pharmaceuticals worth $621K as of Q2 2026.
  • Paces Ferry Wealth Advisors sold 36 Vertex Pharmaceuticals shares in Q2 2026, an estimated $16K.
  • Vertex Pharmaceuticals made up 0.23% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #59 holding.
  • Paces Ferry Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • Paces Ferry Wealth Advisors's Vertex Pharmaceuticals position peaked at $655K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.